Prof. Dr. med. Lukas Bubendorf

Flury-Sutter, Sarah, Heuzeroth, Frederick, Arbelaez, Emilio, Bubendorf, Lukas, Püschel, Heike, Hayoz, Stefanie, & Rentsch, Cyrill A. (2024). Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer [Journal-article]. Canadian Urological Association Journal, 18(7). https://doi.org/10.5489/cuaj.8552

Afferi, Luca, Spahn, Martin, Hayoz, Stefanie, Strebel, Räto T., Rothschild, Sacha I., Seifert, Helge, Özdemir, Berna C., Kiss, Bernhard, Maletzki, Philipp, Engeler, Daniel, Wirth, Gregory, Hadaschik, Boris, Lucca, Ilaria, John, Hubert, Sauer, Andreas, Müntener, Michael, Bubendorf, Lukas, Schneider, Martina, Musilova, Jana, et al. (2024). Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine. BJU International, null. https://doi.org/10.1111/bju.16318

Akhoundova, Dilara, Fischer, Stefanie, Triscott, Joanna, Lehner, Marika, Thienger, Phillip, Maletti, Sina, Jacquet, Muriel, Lubis, Dinda S.H., Bubendorf, Lukas, Jochum, Wolfram, & Rubin, Mark A. (2024). Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course. Diagnostic Pathology, 19. https://doi.org/10.1186/s13000-024-01511-3

Downes, Michelle R., Hartmann, Arndt, Shen, Steven, Tsuzuki, Toyonori, Van Rhijn, Bas W.G., Bubendorf, Lukas, Van Der Kwast, Theodorus H., & Cheng, Liang. (2024). International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1: Comparison of Bladder Cancer Grading System Performance. American Journal of Surgical Pathology, 48, E1–E10. https://doi.org/10.1097/pas.0000000000002059

Flury-Sutter, Sarah, Heuzeroth, Frederick, Arbelaez, Emilio, Bubendorf, Lukas, Püschel, Heike, Hayoz, Stefanie, & Rentsch, Cyrill A. (2024). Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer: Analysis of a prospective registry [Journal-article]. Canadian Urological Association Journal, 18(7). https://doi.org/10.5489/cuaj.8552

Gorbokon, Natalia, Wößner, Niklas, Lennartz, Maximilian, Dwertmann Rico, Sebastian, Kind, Simon, Reiswich, Viktor, Viehweger, Florian, Lutz, Florian, Fraune, Christoph, Luebke, Andreas M., Hube-Magg, Claudia, Menz, Anne, Schlichter, Ria, Krech, Till, Hinsch, Andrea, Burandt, Eike, Sauter, Guido, Simon, Ronald, Steurer, Stefan, et al. (2024). Prevalence of S-methyl-5′-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors from 149 Different Tumor Types. American Journal of Surgical Pathology, 48, 1245–1258. https://doi.org/10.1097/PAS.0000000000002297

Kerr, Keith M, Bubendorf, Lukas, Lopez-Rios, Fernando, Khalil, Farah, Roy-Chowdhuri, Sinchita, Joubert, Philippe, Hartmann, Arndt, Guerini-Rocco, Elena, Yatabe, Yasushi, Hofman, Paul, Cooper, Wendy A, & Dacic, Sanja. (2024). Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists. Histopathology, 84, 429–439. https://doi.org/10.1111/his.15078

Lopez-Beltran, Antonio, Raspollini, Maria R., Hansel, Donna, Compérat, Eva, Williamson, Sean R., Liedberg, Fredrik, Iczkowski, Kenneth A., Bubendorf, Lukas, Van Der Kwast, Theodorus H., & Cheng, Liang. (2024). International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Working Group 3: Subcategorization of T1 Bladder Cancer. American Journal of Surgical Pathology, 48, E24–E31. https://doi.org/10.1097/pas.0000000000002121

Paner, Gladell P., Kamat, Ashish, Netto, George J., Samaratunga, Hemamali, Varma, Murali, Bubendorf, Lukas, Van Der Kwast, Theodorus H., Cheng, Liang, Adeniran, Adebowale, Al-Ahimadie, Hikmat, Algaba, Fernando, Bhattarai, Yves Allory Selina, Black, Peter, Berman, David, Bertz, Simone, Bubendorf, Lukas, Carlsen, Birgitte, Carvalho, Rita, Cheng, Liang, et al. (2024). International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas. American Journal of Surgical Pathology, 48, E11–E23. https://doi.org/10.1097/pas.0000000000002077

Roma, Luca, & Bubendorf, Lukas. (2024). Suggestions for Improving the Comprehensive Characterization of Lung Pleomorphic Carcinoma. Journal of Thoracic Oncology, 19, e38–e39. https://doi.org/10.1016/j.jtho.2024.06.016

Roma, Luca, Ercan, Caner, Conticelli, Floriana, Akyürek, Nalan, Savic Prince, Spasenija, Mertz, Kirsten D., Diebold, Joachim, Lardinois, Didier, Piscuoglio, Salvatore, Ng, Charlotte KY., & Bubendorf, Lukas. (2024). Tracing Tumor Heterogeneity of Pleomorphic Carcinoma of the Lung. Journal of Thoracic Oncology, 19(9), 1284–1296. https://doi.org/10.1016/j.jtho.2024.04.019

Soo, Ross A, Clinthorne, Graham, Santhanagopal, Anu, Wu, Chuntao, Karnoub, Maha, Patel, Parul, & Bubendorf, Lukas. (2024). HER3 is widely expressed across diverse subtypes of NSCLC in a retrospective analysis of archived tissue samples. Future Oncology. https://doi.org/10.1080/14796694.2024.2398983

Speel, Ernst-Jan M., Dafni, Urania, Thunnissen, Erik, Hendrik Rüschoff, Jan, O’Brien, Cathal, Kowalski, Jacek, Kerr, Keith M., Bubendorf, Lukas, Sansano, Irene, Joseph, Leena, Kriegsmann, Mark, Navarro, Atilio, Monkhorst, Kim, Bille Madsen, Line, Hernandez Losa, Javier, Biernat, Wojciech, Stenzinger, Albrecht, Rüland, Andrea, Hillen, Lisa M., et al. (2024). ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project. Lung Cancer, 194. https://doi.org/10.1016/j.lungcan.2024.107860

van der Kwast, Theodorus H., Bubendorf, Lukas, & Cheng, Liang. (2024). International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer: Main Conclusions and Recommendations. European Urology, null. https://doi.org/10.1016/j.eururo.2024.02.009

Van Der Kwast, Theodorus H., Bubendorf, Lukas, & Cheng, Liang. (2024). International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Progresses and Challenges. American Journal of Surgical Pathology, 48, 1–3. https://doi.org/10.1097/pas.0000000000002066

Vlajnic, Tatjana, & Bubendorf, Lukas. (2024). New edition of the Paris classification 2022: What is new? Pathologie. https://doi.org/10.1007/s00292-024-01340-7

Vlajnic, Tatjana, Chijioke, Obinna, Roma, Luca, Savic Prince, Spasenija, Zellweger, Tobias, Rentsch, Cyrill A., & Bubendorf, Lukas. (2024). Loss of MTAP Expression by Immunohistochemistry Is a Surrogate Marker for Homozygous 9p21.3 Deletion in Urothelial Carcinoma. Modern Pathology, 37. https://doi.org/10.1016/j.modpat.2024.100495

Vlajnic, Tatjana, Müller, David C., Ruiz, Christian, Schönegg, René, Seifert, Hans-Helge, Thalmann, George N., Zellweger, Tobias, Le Magnen, Clémentine, Rentsch, Cyrill A., & Bubendorf, Lukas. (2024). Exploring the intratumoral heterogeneity of DNA ploidy in prostate cancer. Cancer Reports, 7. https://doi.org/10.1002/cnr2.1953

Warrick, Joshua I., Al-Ahmadie, Hikmat, Berman, David M., Black, Peter C., Flaig, Thomas W., Höglund, Mattias, Bubendorf, Lukas, Van Der Kwast, Theodorus H., Cheng, Liang, Adeniran, Adebowale, Al-Ahimadie, Hikmat, Algaba, Fernando, Allory, Yves, Bhattarai, Selina, Black, Peter, Berman, David, Bertz, Simone, Bubendorf, Lukas, Carlsen, Birgitte, et al. (2024). International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer - Principles of Classification and Emerging Clinical Utility. American Journal of Surgical Pathology, 48, E32–E42. https://doi.org/10.1097/pas.0000000000002053

Werner, Raphael Sven, Curioni-Fontecedro, Alessandra, Mauti, Laetitia A., Addeo, Alfredo, Peters, Solange, Frauenfelder, Thomas, Puhan, Milo A., Haberecker, Martina, Bubendorf, Lukas, Finazzi, Tobias, Guckenberger, Matthias, Cafarotti, Stefano, Geiser, Thomas, & Opitz, Isabelle. (2024). Lung Cancer in Switzerland. Journal of Thoracic Oncology, 19, 385–394. https://doi.org/10.1016/j.jtho.2023.12.005

Wetterauer, Christian, Matthias, Mark, Pueschel, Heike, Deckart, Alexander, Bubendorf, Lukas, Mortezavi, Ashkan, Arbelaez, Emilio, Jean Winkel, David, Heye, Tobias, Boll, Daniel T., Merkle, Elmar, Hayoz, Stefanie, Seifert, Helge H., & Rentsch, Cyrill A. (2024). Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING). European Urology Focus, 10(2), 332–338. https://doi.org/10.1016/j.euf.2024.02.006

Blakely, Collin M., Weder, Walter, Bubendorf, Lukas, He, Jianxing, Majem, Margarita, Shyr, Yu, & Chaft, Jamie E. (2023). Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review. Lung Cancer, 177, 59–72. https://doi.org/10.1016/j.lungcan.2023.01.002

Canberk, Sule, Field, Andrew, Bubendorf, Lukas, Chandra, Ashish, Cree, Ian A., Engels, Marianne, Hiroshima, Kenzo, Jain, Deepali, Kholová, Ivana, Layfield, Lester, Mehrotra, Ravi, Michael, Claire, Osamura, Robert, Pitman, Martha B., Roy-Chowdhuri, Sinchita, Satoh, Yukitoshi, VanderLaan, Paul, Zakowski, Maureen, & Schmitt, Fernando C. (2023). A brief review of the WHO reporting system for lung cytopathology. Journal of the American Society of Cytopathology, 12, 251–257. https://doi.org/10.1016/j.jasc.2023.04.002

Cathomas, Richard, Rothschild, Sacha I., Hayoz, Stefanie, Bubendorf, Lukas, Özdemir, Berna C., Kiss, Bernhard, Erdmann, Andreas, Aeppli, Stefanie, Mach, Nicolas, Strebel, Räto T., Hadaschik, Boris, Berthold, Dominik, John, Hubert, Zihler, Deborah, Schmid, Mathias, Alborelli, Ilaria, Schneider, Martina, Musilova, Jana, Spahn, Martin, & Petrausch, Ulf. (2023). Perioperative Chemoimmunotherapy with Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17. Journal of Clinical Oncology, 41, 5131–5139. https://doi.org/10.1200/jco.23.00363

Field, Andrew S., Pitman, Martha, Cree, Ian A., Canberk, Sule, Bubendorf, Lukas, Mahrotra, Ravi, & Schmitt, Fernando. (2023). The rationale for the development and publication of the World Health Organization reporting systems for cytopathology and a brief overview of the first editions of the lung and pancreaticobiliary systems. Cancer Cytopathology, 131, 751–761. https://doi.org/10.1002/cncy.22757

Gallon, John, Rodriguez-Calero, Antonio, Benjak, Andrej, Akhoundova, Dilara, Maletti, Sina, Amstutz, Ursula, Hewer, Ekkehard, Genitsch, Vera, Fleischmann, Achim, Rushing, Elisabeth J., Grobholz, Rainer, Fischer, Ingeborg, Jochum, Wolfram, Cathomas, Gieri, Osunkoya, Adeboye O., Bubendorf, Lukas, Moch, Holger, Thalmann, George, Feng, Felix Y., et al. (2023). DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations. Cancer Research, 83, 1203–1213. https://doi.org/10.1158/0008-5472.can-22-2236

Garioni, Michele, Tschan, Viviane J., Blukacz, Lauriane, Nuciforo, Sandro, Parmentier, Romuald, Roma, Luca, Coto-Llerena, Mairene, Pueschel, Heike, Piscuoglio, Salvatore, Vlajnic, Tatjana, Stenner, Frank, Seifert, Hans-Helge, Rentsch, Cyrill A., Bubendorf, Lukas, & Le Magnen, Clémentine. (2023). Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. Npj Precision Oncology, 7. https://doi.org/10.1038/s41698-023-00466-w

Hetzel, Jürgen, Mauti, Laetitia A., Winkler, Jonas, Cardoso Almeida, Sabine, Jermann, Philip, Pless, Miklos, Bubendorf, Lukas, Bode, Peter Karl, & Häntschel, Maik. (2023). Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer. Journal of Clinical Medicine, 12. https://doi.org/10.3390/jcm12062355

König, D., Savic Prince, S., Hayoz, S., Zens, P., Berezowska, S., Jochum, W., Stauffer, E., Braunersreuther, V., Trachsel, B., Thierstein, S., Mark, M., Schmid, S., Curioni-Fontecedro, A., Addeo, A., Opitz, I., Guckenberger, M., Früh, M., Betticher, D.C., Ris, H.-B., et al. (2023). Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14 [Journal-article]. ESMO Open, 8(4), 101595. https://doi.org/10.1016/j.esmoop.2023.101595

Naegele, Klaudia, Weissbach, Fabian H., Leuzinger, Karoline, Gosert, Rainer, Bubendorf, Lukas, & Hirsch, Hans H. (2023). Impact of nucleic acid extraction procedures on human papillomavirus (HPV) detection and genotyping. Journal of Medical Virology, 95. https://doi.org/10.1002/jmv.28583

Peterson, Caspar J., Klasen, Jennifer M., Bubendorf, Lukas, Freitag, Martin, Delko, Tarik, & Lazaridis, Ioannis I. (2023). Parathyroid adenoma mimicking bethesda class III follicular thyroidal lesion: A case report. International Journal of Surgery Open, 57. https://doi.org/10.1016/j.ijso.2023.100612

Peters, Solange, Letovanec, Igor, Mauer, Murielle, Dafni, Urania, Ejedepang, Dunson, Biernat, Wojciech, Bubendorf, Lukas, Warth, Arne, Pokharel, Saraswati, Reinmuth, Niels, Majem Tarruella, Margarita, Casas-Martin, Jose, Tsourti, Zoi, Marti, Nesa, Kammler, Roswitha, Danson, Sarah, O’Brien, Mary, & Stahel, Rolf. A. (2023). Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial. Lung Cancer, 175, 141–151. https://doi.org/10.1016/j.lungcan.2022.12.004

Ruiz, Christian, Alborelli, Ilaria, Manzo, Massimilinao, Calgua, Byron, Keller, Eveline Barbara, Vuaroqueaux, Vincent, Quagliata, Luca, Rentsch, Cyrill A., Spagnoli, Giulio Cesare, Diener, Pierre André, Bubendorf, Lukas, Morant, Rudolf, & Eppenberger-Castori, Serenella. (2023). Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy. Pathobiology, 90, 400–408. https://doi.org/10.1159/000531175

Schmitt, Fernando C., Bubendorf, Lukas, Canberk, Sule, Chandra, Ashish, Cree, Ian A., Engels, Marianne, Hiroshima, Kenzo, Jain, Deepali, Kholová, Ivana, Layfield, Lester, Mehrotra, Ravi, Michael, Claire W., Osamura, Robert, Pitman, Martha B., Roy-Chowdhuri, Sinchita, Satoh, Yukitoshi, Vanderlaan, Paul, Zakowski, Maureen F., & Field, Andrew S. (2023). The World Health Organization Reporting System for Lung Cytopathology. Acta Cytologica, 67, 80–91. https://doi.org/10.1159/000527580

Thunnissen, Erik, Beasley, Mary Beth, Borczuk, Alain, Dacic, Sanja, Kerr, Keith M., Lissenberg-Witte, Birgit, Minami, Yuko, Nicholson, Andrew G., Noguchi, Masayuki, Sholl, Lynette, Tsao, Ming-Sound, Le Quesne, John, Roden, Anja C., Chung, Jin-Haeng, Yoshida, Akihiko, Moreira, Andre L., Lantuejoul, Sylvie, Pelosi, Giuseppe, Poleri, Claudia, et al. (2023). Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee. Journal of Thoracic Oncology, 18, 447–462. https://doi.org/10.1016/j.jtho.2022.11.026

van Gulik, Anna Lena, Sluydts, Ellen, Vervoort, Liesbet, Kockx, Mark, Kortman, Pim, Ylstra, Bauke, Finn, Stephen P., Bubendorf, Lukas, Bahce, Idris, Sie, Daoud, Radonic, Teodora, Lissenberg-Witte, Birgit, & Thunnissen, Erik. (2023). False positivity in break apart fluorescence in-situ hybridization due to polyploidy. Translational Lung Cancer Research, 12, 676–688. https://doi.org/10.21037/tlcr-22-516

Bacon JVW, Müller DC, Ritch E, Annala M, Dugas SG, Herberts C, Vandekerkhove G, Seifert H, Zellweger T, Black PC, Bubendorf L, Wyatt AW, & Rentsch CA. (2022). Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy. European Urology Oncology, 5(6), 677–686. https://doi.org/10.1016/j.euo.2021.11.002

Bubendorf L, Zoche M, Dafni U, Rüschoff JH, Prince SS, Marti N, Stavrou A, Kammler R, Finn SP, Moch H, Peters S, & Stahel RA. (2022). Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort. Lung Cancer (Amsterdam, Netherlands), 174, 27–35. https://doi.org/10.1016/j.lungcan.2022.09.014

Jain D, Nambirajan A, Chen G, Geisinger K, Hiroshima K, Layfield L, Minami Y, Moreira AL, Motoi N, Papotti M, Rekhtman N, Russell PA, Prince SS, Schmitt F, Yatabe Y, Eppenberger-Castori S, Bubendorf L, & IASLC Pathology Committee. (2022). NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 17(6), 793–805. https://doi.org/10.1016/j.jtho.2022.02.013

Malapelle U, Pepe F, Pisapia P, Sgariglia R, Nacchio M, Barberis M, Bilh M, Bubendorf L, Büttner R, Cabibi D, Castiglia M, De Andrea CE, de Biase D, Dumur CI, Fontanini G, Freire J, Gristina V, Hofman P, Ilie M, et al. (2022). TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study. Journal of Clinical Pathology, 75(6), 416–421. https://doi.org/10.1136/jclinpath-2021-207450

Paz-Ares L, Gondos A, Saldana D, Thomas M, Mascaux C, Bubendorf L, & Barlesi F. (2022). Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study. Lung Cancer (Amsterdam, Netherlands), 167, 41–48. https://doi.org/10.1016/j.lungcan.2022.01.021

Vigliar E, Pisapia P, Dello Iacovo F, Alcaraz-Mateos E, Alì G, Ali SZ, Baloch ZW, Bellevicine C, Bongiovanni M, Botsun P, Bruzzese D, Bubendorf L, Büttner R, Canberk S, Capitanio A, Casadio C, Cazacu E, Cochand-Priollet B, D’Amuri A, et al. (2022). COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study. Cancer Cytopathology, 130(5), 344–351. https://doi.org/10.1002/cncy.22547

Rentsch CA, Thalmann GN, Lucca I, Kwiatkowski M, Wirth GJ, Strebel RT, Engeler D, Pedrazzini A, Hüttenbrink C, Schultze-Seemann W, Torpai R, Bubendorf L, Wicki A, Roth B, Bosshard P, Püschel H, Boll DT, Hefermehl L, Roghmann F, et al. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European Urology Oncology, 5(2), 195–202. https://doi.org/10.1016/j.euo.2021.12.006

Bubendorf L. (2022). [Cytopathology-an introduction to the subject]. (Patent No. 2). 43(2), Article 2. https://doi.org/10.1007/s00292-022-01057-5

Vlajnic T, & Bubendorf L. (2022). [Diagnostic and predictive markers in urinary tract cytology]. Der Pathologe, 43(2), 99–104. https://doi.org/10.1007/s00292-022-01053-9

Bubendorf, Lukas, Caraway, Nancy P., Fischer, Andrew H., Katz, Ruth L., Schmitt, Fernando, Fležar, Margareta Strojan, Van der Kwast, Theodorus H., & Vielh, Philippe. (2022). Ancillary Studies in Urinary Cytology: Vol. null (pp. 193–220). Springer International Publishing. https://doi.org/10.1007/978-3-030-88686-8_9

Jain D, & Bubendorf L. (2022). Can cytology reliably subtype non-small cell lung carcinomas? Cytopathology : Official Journal of the British Society for Clinical Cytology, 33(1), 8–13. https://doi.org/10.1111/cyt.13056

Rodriguez-Calero, Antonio, Gallon, John, Akhoundova, Dilara, Maletti, Sina, Ferguson, Alison, Cyrta, Joanna, Amstutz, Ursula, Garofoli, Andrea, Paradiso, Viola, Tomlins, Scott A., Hewer, Ekkehard, Genitsch, Vera, Fleischmann, Achim, Vassella, Erik, Rushing, Elisabeth J., Grobholz, Rainer, Fischer, Ingeborg, Jochum, Wolfram, Cathomas, Gieri, et al. (2022). Alterations in homologous recombination repair genes in prostate cancer brain metastases. Nature Communications, 13. https://doi.org/10.1038/s41467-022-30003-5

Vlajnic T, Brunner P, Eppenberger-Castori S, Rentsch CA, Zellweger T, & Bubendorf L. (2022). High Inter- and Intratumoral Variability of Ki67 Labeling Index in Newly Diagnosed Prostate Cancer with High Gleason Scores. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology, 89(2), 74–80. https://doi.org/10.1159/000519007

Bolis M, Bossi D, Vallerga A, Ceserani V, Cavalli M, Impellizzieri D, Di Rito L, Zoni E, Mosole S, Elia AR, Rinaldi A, Pereira Mestre R, D’Antonio E, Ferrari M, Stoffel F, Jermini F, Gillessen S, Bubendorf L, Schraml P, et al. (2021). Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression. Nature Communications, 12(1), 7033. https://doi.org/10.1038/s41467-021-26840-5

Aggarwal C, Bubendorf L, Cooper WA, Illei P, Borralho Nunes P, Ong BH, Tsao MS, Yatabe Y, & Kerr KM. (2021). Molecular testing in stage I-III non-small cell lung cancer: Approaches and challenges. Lung Cancer (Amsterdam, Netherlands), 162, 42–53. https://doi.org/10.1016/j.lungcan.2021.09.003

Hostettler KE, Tamm M., Bubendorf L, Grendelmeier P., Jahn K., Stolz D., Bremerich J, & Prince SS. (2021). Integration of transbronchial cryobiopsy into multidisciplinary board decision: a single center analysis of one hundred consecutive patients with interstitial lung disease (Patent No. 1). 22(1), Article 1. https://doi.org/10.1186/s12931-021-01821-w

Wetterauer C, Trotsenko P, Matthias MO, Breit C, Keller N, Meyer A, Brantner P, Vlajnic T, Bubendorf L, Winkel DJ, Kwiatkowski M, & Seifert HH. (2021). Diagnostic accuracy and clinical implications of robotic assisted MRI-US fusion guided target saturation biopsy of the prostate. Scientific Reports, 11(1), 20250. https://doi.org/10.1038/s41598-021-99854-0

Servant R, Garioni M, Vlajnic T, Blind M, Pueschel H, Müller DC, Zellweger T, Templeton AJ, Garofoli A, Maletti S, Piscuoglio S, Rubin MA, Seifert H, Rentsch CA, Bubendorf L, & Le Magnen C. (2021). Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. The Journal of Pathology, 254(5), 543–555. https://doi.org/10.1002/path.5698

Finn SP, Addeo A, Dafni U, Thunnissen E, Bubendorf L, Madsen LB, Biernat W, Verbeken E, Hernandez-Losa J, Marchetti A, Cheney R, Warth A, Speel EM, Quinn AM, Monkhorst K, Jantus-Lewintre E, Tischler V, Marti N, Dimopoulou G, et al. (2021). Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 16(6), 990–1002. https://doi.org/10.1016/j.jtho.2021.02.016

Müllhaupt G, Enzler-Tschudy A, Horg K, Bubendorf L, Pratsinis M, Schmid HP, & Abt D. (2021). Informative value of histological assessment of tissue acquired during aquablation of the prostate. World Journal of Urology, 39(6), 2043–2047. https://doi.org/10.1007/s00345-020-03426-2

Hommerding O, Allory Y, Argani P, Bismar TA, Bubendorf L, Canete-Portillo S, Chaux A, Chen YB, Cheng L, Cubilla AL, Egevad L, Gill AJ, Grignon DJ, Hartmann A, Hes O, Idrees MT, Kao CS, Knowles MA, Looijenga LHJ, et al. (2021). [Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference]. Der Pathologe, 42(3), 310–318. https://doi.org/10.1007/s00292-020-00888-4

Mino-Kenudson M, Le Stang N, Daigneault JB, Nicholson AG, Cooper WA, Roden AC, Moreira AL, Thunnissen E, Papotti M, Pelosi G, Motoi N, Poleri C, Brambilla E, Redman M, Jain D, Dacic S, Yatabe Y, Tsao MS, Lopez-Rios F, et al. (2021). The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 16(4), 686–696. https://doi.org/10.1016/j.jtho.2020.12.026

Amrein MA, Bührer ED, Amrein ML, Li Q, Rothschild S, Riether C, Jaggi R, Savic-Prince S, Bubendorf L, Gautschi O, & Ochsenbein AF. (2021). Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study. Cancer Immunology, Immunotherapy : CII, 70(2), 405–415. https://doi.org/10.1007/s00262-020-02688-4

Hofman P, Ilié M, Chamorey E, Brest P, Schiappa R, Nakache V, Antoine M, Barberis M, Begueret H, Bibeau F, Bonnetaud C, Boström P, Brousset P, Bubendorf L, Carvalho L, Cathomas G, Cazes A, Chalabreysse L, Chenard MP, et al. (2021). Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future. ESMO Open, 6(1), 100024. https://doi.org/10.1016/j.esmoop.2020.100024

Vela V, Juskevicius D., Prince SS, Cathomas G, Dertinger S., Diebold J, Bubendorf L, Horcic M., Singer G., Zettl A., Dirnhofer S, Tzankov A, & Menter T. (2021). Deciphering the genetic landscape of pulmonary lymphomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, 34(2), 371–379. https://doi.org/10.1038/s41379-020-00660-2

Fuchs J., Früh M, Papachristofilou A, Bubendorf L, Hauptle P., Jost L, Zippelius A., & Rothschild SI. (2021). Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study. PloS One, 16(6), e0253601. https://doi.org/10.1371/journal.pone.0253601

Haefliger S, Savice Prince S, Rebetez J, Borer H, & Bubendorf L. (2021). Putative Malignant Pleural Mesothelioma in situ (MPMIS) with Sequential Acquisition of Genomic Alterations on Fluorescence in situ Hybridization (FISH) Examination. (Patent No. 1). 65(1), Article 1. https://doi.org/10.1159/000509886

Harris T, Sheel A, Zong Y, Hutchinson LM, Cornejo KM, Bubendorf L, Yates J, & Fischer AH. (2021). Cytologically targeted next-generation sequencing: a synergy for diagnosing urothelial carcinoma. Journal of the American Society of Cytopathology, 10(1), 94–102. https://doi.org/10.1016/j.jasc.2020.10.001

Krause, Arthur, Roma, Luca, Lorber, Thomas, Dietsche, Tanja, Perrina, Valeria, Müller, David C., Lardinois, Didier, Ruiz, Christian, Prince, Spasenija Savic, Piscuoglio, Salvatore, Ng, Charlotte K.Y., & Bubendorf, Lukas. (2021). Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung. Translational Lung Cancer Research, 10, 1792–1803. https://doi.org/10.21037/tlcr-21-48

Moch, Holger, Cathomas, Gieri, Frattini, Milo, Jochum, Wolfram, Vassella, Erik, de Leval, Laurence, Diebold, Joachim, Britschgi, Christian, McKee, Thomas, & Bubendorf, Lukas. (2021). Use of Diagnostic Algorithms for NTRKFusion-Positive Tumors in Pathology Institutes in Switzerland. Healthbook TIMES Oncology Hematology, 7, 14–21. https://doi.org/10.36000/hbt.oh.2021.07.030

Nambirajan A, Dutta R, Malik PS, Bubendorf L, & Jain D. (2021). Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas. Acta Cytologica, 65(1), 67–74. https://doi.org/10.1159/000510323

Vlajnic T, & Bubendorf L. (2021). Molecular pathology of prostate cancer: a practical approach. Pathology, 53(1), 36–43. https://doi.org/10.1016/j.pathol.2020.10.003

Bubendorf L, Conde E, Cappuzzo F, Langfort R, Schildhaus HU, Votruba J, Concha-López Á, Esteban-Rodriguez I, Feng J, Devenport J, Boyiddle C, Morris S, Trunzer K, & Kerr KM. (2020). A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens. Cancer Cytopathology, 128(12), 928–938. https://doi.org/10.1002/cncy.22324

Matter MS, Chijioke O, Savic S, & Bubendorf L. (2020). Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas. Translational Lung Cancer Research, 9(6), 2645–2655. https://doi.org/10.21037/tlcr-20-676

Vigliar E, Cepurnaite R, Alcaraz-Mateos E, Ali SZ, Baloch ZW, Bellevicine C, Bongiovanni M, Botsun P, Bruzzese D, Bubendorf L, Büttner R, Canberk S, Capitanio A, Casadio C, Cazacu E, Cochand-Priollet B, D’Amuri A, Eloy C, Engels M, et al. (2020). Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries. Cancer Cytopathology, 128(12), 885–894. https://doi.org/10.1002/cncy.22373

Bubendorf, Lukas, Firat, Pinar, Kulac, Ibrahim, Pisapia, Pasquale, Savic-Prince, Spasenija, Santos, Gilda, & Troncone, Giancarlo. (2020). Ancillary studies for serous fluids: Vol. null (pp. 129–165). Springer. https://doi.org/10.1007/978-3-030-53908-5_8

Alborelli I, Bratic Hench I, Chijioke O, Prince SS, Bubendorf L, Leuenberger LP, Tolnay M, Leonards K, Quagliata L, Jermann P, & Matter MS. (2020). Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients. Lung Cancer (Amsterdam, Netherlands), 149, 84–89. https://doi.org/10.1016/j.lungcan.2020.08.019

Saliakoura M, Rossi Sebastiano M, Pozzato C, Heidel FH, Schnöder TM, Savic Prince S, Bubendorf L, Pinton P, A Schmid R, Baumgartner J, Freigang S, Berezowska SA, Rimessi A, & Konstantinidou G. (2020). PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia. Nature Cell Biology, 22(11), 1382–1395. https://doi.org/10.1038/s41556-020-00592-8

Moreira AL, Ocampo PSS, Xia Y, Zhong H, Russell PA, Minami Y, Cooper WA, Yoshida A, Bubendorf L, Papotti M, Pelosi G, Lopez-Rios F, Kunitoki K, Ferrari-Light D, Sholl LM, Beasley MB, Borczuk A, Botling J, Brambilla E, et al. (2020). A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 15(10), 1599–1610. https://doi.org/10.1016/j.jtho.2020.06.001

Federer-Gsponer JR, Müller DC, Zellweger T, Eggimann M, Marston K, Ruiz C, Seifert HH, Rentsch CA, Bubendorf L, & Le Magnen C. (2020). Patterns of stemness-associated markers in the development of castration-resistant prostate cancer. The Prostate, 80(13), 1108–1117. https://doi.org/10.1002/pros.24039

Sholl LM, Hirsch FR, Hwang D, Botling J, Lopez-Rios F, Bubendorf L, Mino-Kenudson M, Roden AC, Beasley MB, Borczuk A, Brambilla E, Chen G, Chou TY, Chung JH, Cooper WA, Dacic S, Lantuejoul S, Jain D, Lin D, et al. (2020). The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 15(9), 1409–1424. https://doi.org/10.1016/j.jtho.2020.05.019

Gautschi O, Bubendorf L, Leyvraz S, Menon R, & Diebold J. (2020). Challenges in the Diagnosis of NTRK Fusion-Positive Cancers. (Patent No. 7). 15(7), Article 7. https://doi.org/10.1016/j.jtho.2019.05.001

Lotan TL, Tomlins SA, Bismar TA, Van der Kwast TH, Grignon D, Egevad L, Kristiansen G, Pritchard CC, Rubin MA, & Bubendorf L. (2020). Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer. The American Journal of Surgical Pathology, 44(7), e15–e29. https://doi.org/10.1097/pas.0000000000001450

Huang RSP, Smith D, Le CH, Liu WW, Ordinario E, Manohar C, Lee M, Rajamani J, Truong H, Li J, Choi C, Li J, Pati A, Bubendorf L, Buettner R, Kerr KM, Lopez-Rios F, Marchetti A, Marondel I, et al. (2020). Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization. Archives of Pathology & Laboratory Medicine, 144(6), 735–741. https://doi.org/10.5858/arpa.2019-0085-oa

Alajati A, D’Ambrosio M, Troiani M, Mosole S, Pellegrini L, Chen J, Revandkar A, Bolis M, Theurillat JP, Guccini I, Losa M, Calcinotto A, De Bernardis G, Pasquini E, D’Antuono R, Sharp A, Figueiredo I, Nava Rodrigues D, Welti J, et al. (2020). CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. The Journal of Clinical Investigation, 130(5), 2435–2450. https://doi.org/10.1172/jci131133

Keppens C, Dequeker EMC, Rouleau E, ’t Hart N, Bubendorf L, Dufraing K, Garrec C, Guéguen P, Lamy A, Marchetti A, Pauwels P, Ryska A, Tack V, Tornillo L, Van Casteren K, von der Thüsen JH, Zwaenepoel K, Lissenberg-Witte B, Thunnissen E, & Schuuring E. (2020). Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples. BMC Cancer, 20(1), 366. https://doi.org/10.1186/s12885-020-06831-3

Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, Bunn P, Cascone T, Chaft J, Chen G, Chou TY, Cooper W, Erasmus JJ, Ferreira CG, Goo JM, Heymach J, Hirsch FR, Horinouchi H, Kerr K, et al. (2020). IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 15(5), 709–740. https://doi.org/10.1016/j.jtho.2020.01.005

Lantuejoul S, Sound-Tsao M, Cooper WA, Girard N, Hirsch FR, Roden AC, Lopez-Rios F, Jain D, Chou TY, Motoi N, Kerr KM, Yatabe Y, Brambilla E, Longshore J, Papotti M, Sholl LM, Thunnissen E, Rekhtman N, Borczuk A, et al. (2020). PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 15(4), 499–519. https://doi.org/10.1016/j.jtho.2019.12.107

Liem EIML, Oddens JR, Vernooij RWM, Li R, Kamat A, Dinney CP, Mengual L, Alcaraz A, Izquierdo L, Savic S, Thalmann GN, Bubendorf L, Sylvester RJ, & de Reijke TM. (2020). The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data. The Journal of Urology, 203(2), 283–291. https://doi.org/10.1097/ju.0000000000000566

Vlajnic T, Gut A, Savic S, & Bubendorf L. (2020). The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH. Journal of Clinical Pathology, 73(2), 90–95. https://doi.org/10.1136/jclinpath-2019-206109

Alborelli I, Leonards K, Rothschild SI, Leuenberger LP, Savic Prince S, Mertz KD, Poechtrager S, Buess M, Zippelius A, Läubli H, Haegele J, Tolnay M, Bubendorf L, Quagliata L, & Jermann P. (2020). Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer. The Journal of Pathology, 250(1), 19–29. https://doi.org/10.1002/path.5344

Balmer, Maria L., Ma, Eric H., Thompson, Andrew J., Epple, Raja, Unterstab, Gunhild, Lötscher, Jonas, Dehio, Philippe, Schürch, Christian M., Warncke, Jan D., Perrin, Gaëlle, Woischnig, Anne-Kathrin, Grählert, Jasmin, Löliger, Jordan, Assmann, Nadine, Bantug, Glenn R., Schären, Olivier P., Khanna, Nina, Egli, Adrian, Bubendorf, Lukas, et al. (2020). Memory CD8 + T Cells Balance Pro- and Anti-inflammatory Activity by Reprogramming Cellular Acetate Handling at Sites of Infection. Cell Metabolism, 32, 457–467. https://doi.org/10.1016/j.cmet.2020.07.004

Haefliger S, Jain D, Menter T, Vlajnic T, Savic Prince S, Hopfer H, Mihatsch MJ, & Bubendorf L. (2020). Lamellar Inclusions within Hyperplastic Endoplasmic Reticulum in Benign Mesothelial Cells. Acta Cytologica, 64(6), 572–576. https://doi.org/10.1159/000508757

Haefliger S, Rebetez J, Buser PJ, Dirnhofer S, & Bubendorf L. (2020). Extensive Emperipolesis of Neoplastic Lymphocytes by Mesothelial Cells in Pleural Effusion Cytology in a Case of a Mediastinal T-Cell Lymphoblastic Lymphoma: A Rare but Diagnostically Useful Phenomenon. (Patent No. 3). 64(3), Article 3. https://doi.org/10.1159/000502711

Krause, Arthur, Roma, Luca, Lorber, Thomas, Habicht, James, Lardinois, Didier, De Filippo, Maria Rosaria, Prince, Spasenija Savic, Piscuoglio, Salvatore, Ng, CharlotteKY, & Bubendorf, Lukas. (2020). Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing. Lung Cancer, 150, 132–138. https://doi.org/10.1016/j.lungcan.2020.10.013

Thunnissen, Erik, Kerr, Keith M., Dafni, Urania, Bubendorf, Lukas, Finn, Stephen P., Soltermann, Alex, Biernat, Wojciech, Cheney, Richard, Verbeken, Erik, Warth, Arne, Marchetti, Antonio, Speel, Ernst-Jan M., Pokharel, Saraswati, Quinn, Anne Marie, Monkhorst, Kim, Navarro, Atilio, Madsen, Line Bille, Tsourti, Zoi, Geiger, Thomas, et al. (2020). Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort. Modern Pathology, 33, 792–801. https://doi.org/10.1038/s41379-019-0383-9

Thunnissen E, Lissenberg-Witte BI, van den Heuvel MM, Monkhorst K, Skov BG, Sørensen JB, Mellemgaard A, Dingemans AMC, Speel EJM, de Langen AJ, Hashemi SMS, Bahce I, van der Drift MA, Looijen-Salamon MG, Gosney J, Postmus PE, Samii SMS, Duplaquet F, Weynand B, et al. (2019). ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. Lung Cancer (Amsterdam, Netherlands), 138, 13–18. https://doi.org/10.1016/j.lungcan.2019.09.023

Dugas SG, Müller DC, Le Magnen C, Federer-Gsponer J, Seifert HH, Ruiz C, Savic Prince S, Vlajnic T, Zellweger T, Mertz KD, Bacon JVW, Wyatt AW, Rentsch CA, & Bubendorf L. (2019). Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer. Cancer Cytopathology, 127(9), 578–585. https://doi.org/10.1002/cncy.22167

Hench IB, Cathomas R, Costa L, Fischer N, Gillessen S, Hench J, Hermanns T, Kremer E, Mingrone W, Mestre RP, Püschel H, Rothermundt C, Ruiz C, Tolnay M, Burg PV, Bubendorf L, Vlajnic T, & Sakk SGFCCR. (2019). Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial). Cancers, 11(8). https://doi.org/10.3390/cancers11081099

Alborelli I, Generali D, Jermann P, Cappelletti MR, Ferrero G, Scaggiante B, Bortul M, Zanconati F, Nicolet S, Haegele J, Bubendorf L, Aceto N, Scaltriti M, Mucci G, Quagliata L, & Novelli G. (2019). Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study. Cell Death & Disease, 10(7), 534. https://doi.org/10.1038/s41419-019-1770-3

Savic S, Berezowska S, Eppenberger-Castori S, Cathomas G., Diebold J, Diebold J, Fleischmann A., Jochum W., Komminoth P, McKee T, Letovanec I., Jasarevic Z., Rossle M., Singer G., von Gunten M., Zettl A, Zweifel R., Soltermann A., & Bubendorf L. (2019). PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study. Virchows Archiv : An International Journal of Pathology, 475(1), 67–76. https://doi.org/10.1007/s00428-019-02582-0

Curioni-Fontecedro A, Perentes JY, Gelpke H, Xyrafas A, Bouchaab H, Mach N, Matzinger O, Stojcheva N, Frueh M, Weder W, Cathomas R, Gargiulo P, Bubendorf L, Pless M, Betticher D, Peters S, & Swiss Group of Clinical Cancer Research (SAKK). (2019). Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08). British Journal of Cancer, 120(10), 968–974. https://doi.org/10.1038/s41416-019-0447-0

Jain D, Nambirajan A, Borczuk A, Chen G, Minami Y, Moreira AL, Motoi N, Papotti M, Rekhtman N, Russell PA, Savic Prince S, Yatabe Y, Bubendorf L, & IASLC Pathology Committee. (2019). Immunocytochemistry for predictive biomarker testing in lung cancer cytology. Cancer Cytopathology, 127(5), 325–339. https://doi.org/10.1002/cncy.22137

Kerr KM, Thunnissen E, Dafni U, Finn SP, Bubendorf L, Soltermann A, Verbeken E, Biernat W, Warth A, Marchetti A, Speel EM, Pokharel S, Quinn AM, Monkhorst K, Navarro A, Madsen LB, Radonic T, Wilson J, De Luca G, et al. (2019). A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project. Lung Cancer (Amsterdam, Netherlands), 131, 95–103. https://doi.org/10.1016/j.lungcan.2019.03.012